Melatonin Dosage
Educational content, not medical advice. This article summarises published research on melatonin for general education. It is not a substitute for advice from your doctor or pharmacist, particularly if you take prescription medication, are pregnant or breastfeeding, or are considering melatonin for a child.
Quick Summary
- Melatonin is best understood as a body-clock signal, not a knock-out sleeping pill.
- Well-designed trials have used 0.3–0.5 mg for sleep timing — a fraction of the 5–10 mg sold on most shelves.
- Timing matters at least as much as dose: the strongest results come from taking it ahead of your target bedtime.
- Evidence is strongest for jet lag and a late-running body clock; for chronic insomnia the average gain is around seven minutes.
- Labels are unreliable, and long-term nightly safety remains an open question.
Melatonin Dosage: Why Less Is Often More — and When It Actually Helps
By Peter Benson — Cognitive Enhancement Researcher | 18+ Years Independent Research · Last reviewed: September 2026
Most conversations about melatonin dosage start at the wrong end of the bottle. Shelves are stacked with 5 mg and 10 mg tablets, yet the dose that restored sleep in one of the best-known clinical trials was 0.3 mg — and the bigger lever is often not the number of milligrams at all, but when you take it. This guide sets out what the trials actually used, where melatonin genuinely earns its place, where it underdelivers, and the label and long-term safety questions that rarely make it onto the packaging. It sits within our Sleep & Recovery hub, which covers the behavioural foundations that make any sleep supplement more or less useful.
The short version: melatonin is a well-studied tool for shifting the timing of sleep — jet lag and a late-running body clock in particular. It is a far weaker tool for chronic insomnia, and there is little good evidence that more milligrams buy proportionally more benefit. If you are building a wider evidence-based stack, our Nootropics & Supplements guide explains how we grade compounds like this one.
💊 Melatonin Dosage & Timing
Doses used in the trials — a starting reference, not a prescription.
Melatonin Is a Timing Signal, Not a Sedative
Melatonin is a hormone your brain releases in response to darkness, and its main job is to help set the timing of your circadian rhythms — the roughly 24-hour clock that decides when you feel alert and when you feel sleepy. Light at night suppresses its release, which is why late-evening screens and bright rooms matter (NCCIH). The practical consequence is that supplemental melatonin is best thought of as a message to your body clock that night has begun, rather than a switch that forces sleep. For the light side of that equation, see our guides to circadian rhythm optimisation and blue light and screens.
That framing also explains a regulatory quirk. In the United States melatonin is sold as a dietary supplement, whereas several other countries treat it as a medicine available only on prescription (NCCIH) — including the United Kingdom (American Heart Association). Readers outside the US may find that the choice of dose is largely made for them by a prescriber.
The 0.3 mg Finding — and Why It Isn’t the Whole Story
The case for low doses traces largely to a double-blind, placebo-controlled trial at MIT. Adults over 50 — fifteen with confirmed insomnia and fifteen normal sleepers — each took placebo and three doses of melatonin (0.1, 0.3 and 3.0 mg) half an hour before bed, a week at a time. The 0.3 mg dose restored sleep efficiency in the insomniacs and brought their night-time melatonin levels back into the normal range. The 3.0 mg dose also improved sleep, but it lowered body temperature and left melatonin elevated into the daylight hours. Normal sleepers saw no benefit from any dose (Zhdanova et al., 2001).
Two details in that result get lost in retelling. First, 3 mg did not fail — it worked, with more carry-over into the next day. Second, this was a small trial in older adults with low natural melatonin, so it cannot tell us what the ideal dose is for a 30-year-old with a late body clock.
The broader evidence is genuinely mixed on dose. A meta-analysis of 19 trials involving 1,683 people with primary sleep disorders found that melatonin shortened the time to fall asleep by about seven minutes and added about eight minutes of total sleep — and that trials using higher doses and running for longer showed larger effects on both measures (Ferracioli-Oda et al., 2013). In jet-lag trials, 0.5 mg and 5 mg were broadly similar overall, though people fell asleep faster and slept better on 5 mg; doses above 5 mg added nothing (Herxheimer & Petrie, Cochrane review).
The honest conclusion, then, is not that low doses are better. It is that low doses are a sensible starting point: they sit close to what the body produces naturally, they leave less hormone circulating into the morning, and the evidence that multiplying the dose delivers proportionally more sleep is thin. Common retail doses of 3–10 mg are ten to thirty times the 0.3 mg that worked in the MIT trial — a gap worth knowing about before you assume the bigger number is the stronger product.
Timing Often Beats Milligrams
The clearest demonstration of well-timed low-dose melatonin comes from people with delayed sleep-wake phase disorder — the pattern of being unable to fall asleep until the early hours and struggling to wake. In a randomised, double-blind trial of 116 patients, 0.5 mg of fast-release melatonin taken one hour before their desired bedtime, combined with actually going to bed at that time on at least five nights a week, moved sleep onset 34 minutes earlier than placebo over four weeks. Clinicians rated 52.8% of the melatonin group as improved, against 24.0% on placebo (Sletten et al., 2018).
Notice what did the work: a small dose, a consistent time before the target bedtime, and a behavioural schedule alongside it. Jet lag follows the same logic. The Cochrane review found that eight of ten trials showed less jet lag with melatonin, with the benefit most likely for travellers crossing five or more time zones — especially flying east — and dosing aligned to bedtime at the destination (Cochrane review). A slow-release formulation performed worse than fast-release in those trials, suggesting a clear, short-lived pulse is what the clock responds to.
Chronic Insomnia: Where Melatonin Underdelivers
This is where expectations and evidence diverge most. An average gain of around seven minutes in sleep onset (Ferracioli-Oda et al.) is real but modest, and it is smaller than for prescription hypnotics. The American Academy of Sleep Medicine’s 2017 guideline issued a weak recommendation that clinicians not use melatonin to treat chronic sleep-onset or sleep-maintenance insomnia in adults. The guideline is explicit that a weak recommendation reflects lower certainty in the evidence and should not be read as proof of ineffectiveness (Sateia et al., 2017).
For chronic insomnia, the American College of Physicians recommends cognitive behavioural therapy for insomnia (CBT-I) as the first-line treatment (NCCIH summary of guidelines). If your problem is lying awake with a racing mind rather than a clock that runs late, melatonin is unlikely to be the answer on its own. Our comparison of the best supplements for sleep and our deep dive on magnesium glycinate for sleep cover the options that target different mechanisms.
The Label Problem: What’s Actually in the Bottle
Choosing a dose assumes the label is accurate, and for melatonin that assumption is shaky. A Canadian analysis of 31 supplements from 16 brands found actual melatonin content ranging from 83% below to 478% above the labelled amount, with more than 71% of products falling outside a 10% margin. Lot-to-lot variation within a single product reached 465%, and 26% of the products contained serotonin, which was not listed (Erland & Saxena, 2017).
A later US study of 25 melatonin gummy products found the measured melatonin ranged from 74% to 347% of the labelled quantity; 22 of the 25 (88%) fell outside ±10% of the label, and one product contained no detectable melatonin at all but did contain 31.3 mg of CBD (Cohen et al., 2023). The practical upshot: an independent third-party testing seal is the most useful safeguard available, and precise dose-finding is only as reliable as the product you use.
Nightly, Long-Term Use: The Open Question
Short-term use appears safe for most adults, with mild side effects such as headache, dizziness, nausea and sleepiness. What is missing is good information on long-term safety, especially at doses above what the body normally produces. Melatonin may also stay active for longer in older people, causing daytime drowsiness (NCCIH).
One recent signal deserves mention precisely because it is preliminary. An observational analysis of electronic health records from 130,828 adults with insomnia found that people with at least a year of documented melatonin use had higher rates of new heart failure over five years than matched non-users (4.6% versus 2.7%). The researchers themselves stress that this was a conference abstract, not a peer-reviewed paper, that it cannot establish cause and effect, that over-the-counter users may have been misclassified as non-users, and that worse insomnia or depression could drive both melatonin use and heart risk (American Heart Association). It is a reason for caution about indefinite nightly use, not evidence that melatonin damages the heart.
Children are a separate concern. Reports to US poison control centres of melatonin ingestion by people aged 19 and under rose from 8,337 in 2012 to 52,563 in 2021, mostly accidental ingestion by young children at home; most had no symptoms, but hospitalisations also rose (NCCIH). Gummies in particular should be stored like medicine, and any use in children discussed with a paediatrician first.
Worked Example: Using Melatonin for an Eastward Flight
Here is how the principles above translate into a concrete plan for a flight that crosses five time zones eastward — say, from New York to London, landing in the morning. This is a method illustration built from the trial protocols, not a prescription.
Before you fly
Pick your destination bedtime in advance — for example, 23:00 London time. Buy a third-party-tested, fast-release product at a low dose so you are not guessing at what’s inside.
Arrival day
Get outdoor daylight in the late morning and early afternoon, and avoid a long nap. At about 23:00 London time — still early evening by your body clock — take the lowest studied dose (0.5 mg) and go to bed at that time.
Nights 2–4
Repeat the same dose at the same local bedtime. The Cochrane trials dosed for two to five nights after arrival; there is no need to continue once you are sleeping on local time.
If sleep onset is still poor
The trials suggest a higher dose (up to 5 mg) may help you fall asleep faster, but doses above 5 mg added nothing. Adjust once, not nightly.
Afterwards
Stop. Melatonin for jet lag is a short course, not a new nightly habit.
The same structure — fixed target time, lowest studied dose, a defined trial period, then a deliberate decision — works for a late-running body clock at home. The difference is the trial length: the delayed-sleep-phase study ran for four weeks. Our four-week self-testing method shows how to log the result honestly rather than relying on how you feel on a given morning.
Evidence Hierarchy: What Melatonin Does and Doesn’t Do
| Rating | Claim | What the evidence shows |
|---|---|---|
| 🟢 Well supported | Reducing jet lag, particularly eastward across five or more time zones | Cochrane review: 8 of 10 trials positive; 0.5–5 mg effective, no gain above 5 mg |
| 🟡 Real but qualified | Advancing a late body clock (delayed sleep-wake phase disorder) | One well-run RCT (0.5 mg, 1 h before desired bedtime + fixed schedule); guideline support is weak |
| 🟡 Real but qualified | Low doses working as well as high doses | Supported in a small trial of older adults; a meta-analysis found larger effects with higher doses |
| 🟡 Real but qualified | Helping chronic insomnia | Average gain ~7 minutes to sleep onset; AASM gives a weak recommendation against use |
| 🔴 Commonly claimed, not supported | That 10 mg works far better than a low dose | Head-to-head data show at most a modest edge for higher doses, and none above 5 mg for jet lag |
| 🔴 Commonly claimed, not supported | That the label tells you what you’re taking | Independent testing found content from −83% to +478% of label |
| 🔴 Commonly claimed, not supported | That years of nightly use are established as safe | Long-term safety data are lacking; an unreviewed abstract raises a heart-failure signal |
Named Protocol
The NeuroEdge Low-and-Timed Melatonin Protocol
1 · Name the job: Jet lag or a late body clock? Melatonin fits. Chronic racing-mind insomnia? Start with CBT-I and sleep behaviour instead.
2 · Start at the studied floor: 0.3–0.5 mg of a third-party-tested, fast-release product.
3 · Time it to the target: About an hour before your desired bedtime — or at local bedtime after travel.
4 · Pair it with light and schedule: Morning daylight, dim evenings, and a fixed bedtime do much of the work.
5 · Set an end date: A few nights for travel; a defined, logged trial for body-clock shifting. Then decide deliberately.
Peter’s Testing Notes
Melatonin is not part of my nightly stack, and that is deliberate. I treat it as a travel and clock-shifting tool rather than a sleep aid, and I reach for it for a few nights around long eastward flights rather than as a habit.
The direction I’ve noticed matches the trial logic: when I’ve used it, the low end and the timing have mattered more than the milligrams, and larger doses tended to leave a heavier, slower start to the next morning. These are impressions, not measurements — which is exactly why I’d urge anyone trialling it to keep a simple written log rather than trusting a single good night.
Illustrative Scenarios
Illustrative examples, not real individuals or testimonials. These are composite scenarios built to show how the evidence applies to different situations. Individual responses vary, and these are not typical results.
The late-running remote worker
Someone who cannot fall asleep before 2 a.m. and struggles with a 9 a.m. start. This is the pattern the delayed-sleep-phase trial addressed, so the evidence-matched approach is a low dose about an hour before the target bedtime, a fixed bedtime, morning light, and a four-week logged trial.
The frequent eastbound traveller
A consultant flying east across five or more time zones several times a year. The jet-lag evidence is the strongest in this article, so a short course at destination bedtime fits well — and stopping once on local time is part of the plan.
The nightly 10 mg user
Someone taking a high-dose gummy every night for years for general insomnia. The evidence suggests the benefit is likely small, the dose far above what trials needed, and long-term safety unsettled — a conversation with a GP about CBT-I is the better next step.
Sourcing Standards
I don’t recommend a specific melatonin product here, and there are no affiliate links on this page. Because it isn’t in my own stack, I have no first-hand basis for naming a brand. What to look for instead:
- An independent third-party testing seal — given the label-accuracy findings, this matters more than price.
- Plain immediate-release melatonin, with no added herbs or CBD that make the true dose harder to judge.
- A genuine low-dose option (0.3–0.5 mg) or a scored tablet, rather than breaking up a 10 mg gummy.
- Child-resistant packaging, stored out of reach — especially for gummies.
⚠️ Cautions & Interactions
The least-known interaction: fluvoxamine, an antidepressant used for OCD, can raise melatonin levels and cause excessive drowsiness. Caution also applies to other medicines processed by the same liver enzymes (CYP1A2 and CYP2C19), such as diazepam (Mayo Clinic).
Key drug interactions: blood thinners and anti-platelet drugs (possible bleeding risk); anticonvulsants (possible reduced seizure control, particularly in children with neurological disabilities); immunosuppressants; blood-pressure and diabetes medication; hormonal contraceptives; and sedatives or other CNS depressants, which add to drowsiness (Mayo Clinic). People with epilepsy or on blood thinners should use melatonin only under medical supervision (NCCIH).
Who should avoid it or check first: people with autoimmune conditions; pregnant or breastfeeding women, for whom safety research is lacking; people with dementia, for whom the AASM advises against use; and children, where use should be discussed with a paediatrician (Mayo Clinic; NCCIH).
Main side effects: headache, dizziness, nausea and next-day drowsiness. Do not drive or operate machinery within five hours of taking it.
Before surgery: tell your surgical and anaesthetic team about any melatonin use, because of its additive sedative effect with other medicines.
This is not a complete list. Talk to your doctor or pharmacist before starting melatonin if you take any regular medication or have a medical condition.
Key Takeaways
- Melatonin shifts when you sleep more reliably than it deepens how you sleep.
- Trials have used 0.3–0.5 mg for sleep timing; higher doses may help a little more but add next-day carry-over.
- Take it ahead of your target bedtime, alongside morning light and a fixed schedule.
- Jet lag is the best-supported use; chronic insomnia is better served by CBT-I first.
- Choose third-party-tested products, keep gummies away from children, and set an end date.
Frequently Asked Questions
What is the best melatonin dosage for sleep?
There is no single best dose, but well-run trials have used 0.3–0.5 mg for sleep timing and 0.5–5 mg for jet lag. Starting at the low end is sensible because it is closer to natural levels and leaves less hormone circulating the next morning. Doses above 5 mg showed no extra benefit for jet lag.
When should I take melatonin?
For shifting a late body clock, trials gave it about one hour before the desired bedtime, combined with a fixed bedtime. For jet lag, the trials used it at local bedtime at the destination for two to five nights.
Is it safe to take melatonin every night?
Short-term use appears safe for most adults, but there is little good information on long-term nightly use. A preliminary, unreviewed study linked long-term use to higher heart-failure rates, though it could not show cause and effect. It is sensible to set an end date and discuss ongoing use with your doctor.
Why does melatonin leave me groggy in the morning?
Higher doses can keep melatonin levels raised into the daytime — in one trial in older adults, 3 mg did exactly that while 0.3 mg did not. Taking it too late, or a product containing more than its label states, can have the same effect.
Does melatonin work for jet lag?
Yes — jet lag is its best-supported use. A Cochrane review found eight of ten trials showed less jet lag with melatonin, especially for travellers flying east across five or more time zones.
Get “7 Days to a Sharper Brain” — Free
Peter Benson’s personal daily protocol, rebuilt from 18 years of testing.
- ✓ Day 1 — Sleep foundation + Magnesium Glycinate
- ✓ Day 2 — L-Theanine + Caffeine focus stack
- ✓ Day 3 — Brain nutrition timing for stable energy
- ✓ Day 4 — BDNF movement protocol
- ✓ Day 5 — 90-60-30 sleep environment sequence
- ✓ Day 6 — Stress resilience + cognitive load framework
- ✓ Day 7 — Neuroplasticity, Lion’s Mane + your complete assembled daily stack
Join 2,000+ readers optimising their cognitive performance. Unsubscribe anytime.
Peter Benson
Cognitive Enhancement Researcher | 18+ Years Independent Research
Peter reviews the clinical evidence behind cognitive-performance supplements and protocols, separating what the research supports from what the marketing claims. This content is educational and not medical advice.
Last reviewed: September 2026
References
- Zhdanova IV, Wurtman RJ, Regan MM, Taylor JA, Shi JP, Leclair OU. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab. 2001;86(10):4727–4730. PMID: 11600532. View source
- Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8(5):e63773. PMID: 23691095. View source
- Sletten TL, Magee M, Murray JM, et al. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: a double-blind, randomised clinical trial. PLoS Med. 2018;15(6):e1002587. PMID: 29912983. View source
- Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev. 2002;(2):CD001520. PMID: 12076414. View source
- Erland LAE, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. J Clin Sleep Med. 2017;13(2):275–281. PMID: 27855744. View source
- Cohen PA, Avula B, Wang YH, Katragunta K, Khan I. Quantity of melatonin and CBD in melatonin gummies sold in the US. JAMA. 2023;329(16):1401–1402. PMID: 37097362. View source
- Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307–349. PMID: 27998379. View source
- National Center for Complementary and Integrative Health (NIH). Melatonin: What You Need To Know. Last updated May 2024. View source
- Mayo Clinic Staff. Melatonin. Mayo Clinic, updated August 2025. View source
- American Heart Association Newsroom. Long-term use of melatonin supplements to support sleep may have negative health effects (Nnadi E, et al. Abstract, AHA Scientific Sessions 2025 — preliminary, not peer-reviewed). November 2025. View source
